Developing a European Framework for Research on Children’s Medicines

An Examination of the Proposed EU Regulation on Medicinal Products for Paediatric Use; 25–26 January 2005, Brussels, Belgium
  • Hannsjörg W. Seyberth
  • Jacques Demotes-Mainard
  • Peter Wrobel
Meeting Report


Joint United Nations Programme Paediatric Clinical Trial Proposed Regulation European Clinical Research Infrastructure Network Paediatric Clinical Research 



© European Forum for Good Clinical Practice (EFGCP), 2005. All rights in this document are reserved by the EFGCP, a not-for-profit organisation chartered under Belgian law. The EFGCP hereby gives permission for this document to be freely reviewed, abstracted, reproduced, or translated, provided it receives a copy of such. This document may not be sold in conjunction with commercial purposes without the express written permission of the EFGCP.

The conference received funding from Boehringer Ingelheim; Chiesi Farmaceutici SpA; Genzyme; GlaxoSmithKline Biologicals; Hoffman-La Roche Pharmaceuticals; Les Pharmaceutical Enterprises du Médicament (LEEM); Novartis Pharmaceuticals; Pfizer UK; Pharmaceutical Research & Manufacturers of America (PhRMA); Schering AG; Schering Plough; Solvay Pharmaceuticals.

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Hannsjörg W. Seyberth
    • 1
  • Jacques Demotes-Mainard
    • 2
  • Peter Wrobel
    • 3
  1. 1.Philipps UniversityMarburgGermany
  2. 2.Institut National de la Santé et de la Recherche Médicale (INSERM)BordeauxFrance
  3. 3.European Forum for Good Clinical PracticeBrusselsBelgium

Personalised recommendations